@msn81 OK it sounds like MM thinks they won't need to do anymore phase 2 trials. This doesn't of course mean they won't as this will depend on the outcome of the talks with potential large pharma partners. If they want more phase 2 data before committing the funds to a phase 3 trial they will have to do more phase 2 trials.
I take it from your response that nobody specifically asked if the cell-associated virus data will be released next week?
I don't really have much more to add until the conference data is released.
more key words: potential partners, page-72
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
0.001(2.63%) |
Mkt cap ! $17.59M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 2.0¢ | 1.9¢ | $11.54K | 604.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 1466986 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 830622 | 7 |
View Market Depth
| Last trade - 15.55pm 15/11/2024 (20 minute delay) ? |
| BIT (ASX) Chart |